Targeted News Service

UT Health San Antonio Launches Clinical Trial to Study Rapamycin and Healthy Aging
March 26, 2026

SAN ANTONIO, Texas, March 26 -- The University of Texas Health San Antonio issued the following news release:

* * *

UT Health San Antonio launches clinical trial to study rapamycin and healthy aging

UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio) is launching a multi-phase clinical study to better understand how the drug rapamycin may promote healthy aging. Funded by the National Institute on Agin . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form